ABEO
ABEO
NASDAQ · Biotechnology

Abeona Therapeutics Inc

$7.46
+0.06 (+0.81%)
As of Aug 15, 2:04 AM ET ·
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 11 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target +88.9% upside
Low Target $7.81
Average Target $14.09
High Target $15.42
Current Price $7.46
Current
$7.46
Target
$14.09
$7.81 $14.09 avg $15.42
Scenario Analysis
Bear Case
$7.81
4.7%
Low target
Base Case
$14.09
+88.9%
Avg target
Bull Case
$15.42
+106.7%
High target
Risk/Reward
22.7x
Highly favorable
Price in Context
52-Week High
$7.65
-2.5% from high
52-Week Low
$4.00
+86.5% from low
Target vs 52W High
$14.09
+84.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 +3.3%
AMGN
Amgen Inc
Hold 43 49% $190.87 -54.0%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.1%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 37 81% $438.34 -13.3%
REGN
Regeneron Pharmaceuticals
Buy 37 70% $76.80 -90.4%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -53.9%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -44.0%
BIIB
Biogen Inc
Buy 43 67% $91.45 -56.4%